Clinical Trial Update: Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating trametinib with or without GSK2141795 in metastatic uveal melanoma; results posted in 2020 and the trial is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• GSK2141795 (GSK2141795)
• Trametinib (Mekinist) (trametinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2020-02-24